System and method for discriminating high frequency electromagnetic interference from cardiac events

• US 7,693,574 B2
• Filed: 08/31/2005
• Issued: 04/06/2010
• Est. Priority Date: 08/31/2005
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Wessels, Richard
• Primary Examiner(s): Evanisko; George R
• Assistant Examiner(s): PATTON, AMANDA K
• Application Number:
  US11/216,886
• Publication Number:
  US 20070049995A1
• Time in Patent Office: 1,679 Days
• Field of Search: 607/9, 607/27, 128/901
• US Class Current: 607/9
• CPC Class Codes: A61N 1/37 Monitoring; Protecting
• CPC Class Codes: A61N 1/3718 Monitoring of or protection against external electromagnetic fields or currents

Abstract

A method for discriminating electromagnetic interference from a received signal in an implantable medical device includes identifying a frequency component in the input signal that corresponds to electromagnetic interference. The method further includes passing the physiologic frequency component through a bandpass filter, passing the electromagnetic frequency component through a high pass filter in parallel with the bandpass filter, detecting the electromagnetic frequency component from the high pass filter and using the detected EMI to mitigate one or more effects of the electromagnetic frequency component from the physiologic parameter signal passed by the bandpass filter. An implantable device for detecting a predetermined physiologic event includes an electromagnetic interference (EMI) detection module operable to receive a signal characteristic of a physiologic phenomenon, the received signal comprising a plurality of frequency components, the EMI detection module further operable to output a signal identifying frequency components associated with EMI that is included in the received signal; and a mitigation module operable to use the signal output from the EMI detection module to mitigate one or more effects of the frequency components associated with EMI from the received signal.

Claims

1. An implantable device for detecting a physiologic event, the device comprising:

an electromagnetic interference (EMI) detection module operable to receive an input signal characteristic of the physiologic event, the input signal including physiologic event components and EMI components, the EMI components including high frequency EMI components, and the EMI detection module being further operable to attenuate the physiologic event components and to pass the high frequency EMI components in an output signal; and

a signal conditioning module operable to generate a filtered signal from the input signal, the filtered signal having the high frequency EMI components removed; and

a mitigation module operable to use the high frequency EMI components in the output signal from the EMI detection module to remove the EMI components from the filtered signal.

2. The implantable device recited in claim 1, wherein the signal conditioning module includes a bandpass filter having an upper cutoff frequency and a lower cutoff frequency, the bandpass filter operable to receive the input signal, and output a range of frequency components including at least a portion of the EMI components, and wherein the implantable device further comprises:

a timing module operable to synchronize the output signal with the frequency components passed by the bandpass filter,

wherein the EMI detection module includes a high pass filter, the high pass filter having a cutoff frequency that is lower than the upper cutoff frequency of the bandpass filter.

3. The implantable device recited in claim 2, further comprising a data processor adapted to generate electrocardiogram (egram) data and timing control data based on output from the bandpass filter, wherein the mitigation module comprises the timing module, and further comprises a decision module, which generates tagged EMI data based on output from the detection module, the egram data, and timing control data, and wherein the tagged EMI data is used to mitigate the effects of the EMI.

4. The implantable device recited in claim 2 wherein the timing module comprises a counter counting packets in frames of data in the signal and setting a flip-flop when a maximum number of packets is counted.

5. The implantable medical device as recited in claim 2, wherein the signal conditioning module includes a feedthrough filter for filtering the frequency components of the received signal prior to being filtered by the bandpass filter, and further wherein the frequency components of the received signal directed to the EMI detection module are filtered by the feedthrough filter but bypass the bandpass filter.

6. An implantable medical device for administering therapy in a body of a patient in response to detecting a physiologic event of interest, the device comprising:

a physiologic event detection module for receiving an input signal composed of a plurality of frequency components including physiologic event components and EMI components, the physiologic event detection module comprising;

a bandpass filter for passing the frequency components that are between an upper cutoff frequency and a lower cutoff frequency;

an electromagnetic interference (EMI) detection module for attenuating the physiologic event components and for passing high frequency components characteristic of the EMI components, wherein the high frequency components have a frequency of at least around 1 kHz; and

a mitigation module for using the high frequency components characteristic of the EMI component from the EMI detection module to remove the EMI components from the frequency components passed by the bandpass filter, thereby enabling detection of the physiologic event.

7. The implantable medical device as recited in claim 6 wherein the mitigation module comprises a timing control module and a decision module operable to identify one or more frequency components associated with EMI.

8. The implantable medical device as recited in claim 6 wherein the EMI detection module comprises a high pass filter and a peak detector.

9. The implantable medical device as recited in claim 6 wherein the physiologic event detection module further comprises a timing and control module operable to synchronize frequency components passed by the EMI detection module with frequency components passed by the bandpass filter.

10. The implantable medical device as recited in claim 6 further comprising a therapy administration component receiving output from the physiologic event detection module and responsively administering therapy.

11. The implantable medical device as recited in claim 10 wherein the therapy administration component comprises a pulse generator.

12. The implantable medical device as recited in claim 10 wherein the therapy administration component comprises a defibrillator.

13. The implantable medical device as recited in claim 10 wherein the effects of the frequency components passed by the bandpass filter that are characteristic of EMI are selected from a group comprising:

increased therapy rate, inhibition of required therapy, and inappropriate therapy.